GL1X · GenesisL1 explorer

MolNFT v1 · #117574 · protein

Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9A and a fragment of the coactivator TIF2

5EC9 · Retinoic acid receptor rxr-alpha: “Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9A and a fragment of the…”. X-ray diffraction, 1 ligand (5LO), 2 pockets (best druggability 0.83). MolNFT v1…

PDB
5EC9
Type
protein
Length
221 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor rxr-alpha; Lys-his-lys-ile-leu-his-arg-leu-leu-gln-asp
UniProt
P19793
Ligands
5LO
Pockets
2 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 71% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor rxr-alphaprotein21070% helix, 3% strandP19793
BLys-his-lys-ile-leu-his-arg-leu-leu-gln-aspprotein1173% helix, 0% strand—

Ligands and binding sites

  • 5LO · 4-[(11S,15R)-4,4,7,7-Tetramethyl-16-oxatetracyclo[8.6.0.03,8.011,15]hexadeca-1(10),2,8-trien-11-yl]benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13580.830.92465LO
2690.340.7620empty

Interfaces

1 interface between chains.

  • A–B · 589 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 5EC9 · Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9a and… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.